ArticleCancers2026

Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy.

Rut Meseguer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.